AIM IMMUNOTECH INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
AIM IMMUNOTECH INC. (AIM) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$3.80 million for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-16.
Discontinued › Income Statement
us-gaap:ProfitLoss · last filed 2015-11-16
- AIM IMMUNOTECH INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2015-09-30 was -$3.80M.
- AIM IMMUNOTECH INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2015-06-30 was -$4.84M.
- AIM IMMUNOTECH INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2015-03-31 was -$3.44M.
- AIM IMMUNOTECH INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2014-12-31 was -$4.46M.
- AIM IMMUNOTECH INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2014 was -$17.45M.
- AIM IMMUNOTECH INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2013 was -$16.23M.
- AIM IMMUNOTECH INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2012 was -$17.35M.
- AIM IMMUNOTECH INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2011 was -$9.02M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2015-09-30 | -$3.80M 10-Q · filed 2015-11-16 | -$8.65M derived: sum of 2 quarters · filed 2015-11-16 | -$12.09M 10-Q · filed 2015-11-16 | -$16.55M derived: sum of 4 quarters · filed 2015-11-16 |
| 2015-06-30 | -$4.84M 10-Q · filed 2015-08-12 | -$8.29M 10-Q · filed 2015-08-12 | -$12.75M derived: sum of 3 quarters · filed 2015-08-12 | -$16.95M derived: sum of 4 quarters · filed 2015-11-16 |
| 2015-03-31 | -$3.44M 10-Q · filed 2015-05-12 | -$7.90M derived: sum of 2 quarters · filed 2015-05-12 | -$12.10M derived: sum of 3 quarters · filed 2015-11-16 | -$17.06M derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-12-31 | -$4.46M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | -$8.66M derived: sum of 2 quarters · filed 2015-11-16 | -$13.61M derived: sum of 3 quarters · filed 2015-11-16 | -$17.45M 10-K · filed 2015-03-19 |
| 2014-09-30 | -$4.20M 10-Q · filed 2015-11-16 | -$9.16M derived: sum of 2 quarters · filed 2015-11-16 | -$12.99M 10-Q · filed 2015-11-16 | -$16.19M derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-06-30 | -$4.96M 10-Q · filed 2015-08-12 | -$8.79M 10-Q · filed 2015-08-12 | -$11.99M derived: sum of 3 quarters · filed 2015-08-12 | -$17.12M derived: sum of 4 quarters · filed 2015-08-12 |
| 2014-03-31 | -$3.84M 10-Q · filed 2015-05-12 | -$7.03M derived: sum of 2 quarters · filed 2015-05-12 | -$12.17M derived: sum of 3 quarters · filed 2015-05-12 | -$16.45M derived: sum of 4 quarters · filed 2015-05-12 |
| 2013-12-31 | -$3.19M 10-K · filed 2014-03-14 | -$8.33M derived: sum of 2 quarters · filed 2014-11-07 | -$12.61M derived: sum of 3 quarters · filed 2014-11-07 | -$16.23M 10-K · filed 2015-03-19 |
| 2013-09-30 | -$5.14M 10-Q · filed 2014-11-07 | -$9.42M derived: sum of 2 quarters · filed 2014-11-07 | -$13.03M 10-Q · filed 2014-11-07 | -$18.49M derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-06-30 | -$4.28M 10-Q · filed 2014-08-08 | -$7.89M 10-Q · filed 2014-08-08 | -$13.35M derived: sum of 3 quarters · filed 2014-08-08 | -$19.94M derived: sum of 4 quarters · filed 2014-08-08 |
| 2013-03-31 | -$3.61M 10-Q · filed 2014-05-09 | -$9.07M derived: sum of 2 quarters · filed 2014-05-09 | -$15.66M derived: sum of 3 quarters · filed 2014-05-09 | -$18.66M derived: sum of 4 quarters · filed 2014-05-09 |
| 2012-12-31 | -$5.46M 10-K · filed 2014-03-14 | -$12.05M derived: sum of 2 quarters · filed 2014-03-14 | -$15.05M derived: sum of 3 quarters · filed 2014-03-14 | -$17.35M 10-K · filed 2015-03-19 |
| 2012-09-30 | -$6.59M 10-K · filed 2014-03-14 | -$9.59M derived: sum of 2 quarters · filed 2014-03-14 | -$11.89M 10-Q · filed 2013-11-08 | -$15.01M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | -$3.00M 10-K · filed 2014-03-14 | -$5.31M 10-Q · filed 2013-08-09 | -$8.42M derived: sum of 3 quarters · filed 2014-03-14 | -$11.16M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | -$2.31M 10-K · filed 2014-03-14 | -$5.42M derived: sum of 2 quarters · filed 2014-03-14 | -$8.16M derived: sum of 3 quarters · filed 2014-03-14 | -$10.46M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | -$3.12M 10-K · filed 2013-03-18 | -$5.86M derived: sum of 2 quarters · filed 2013-03-18 | -$8.15M derived: sum of 3 quarters · filed 2013-03-18 | -$9.02M 10-K · filed 2014-03-14 |
| 2011-09-30 | -$2.74M 10-K · filed 2013-03-18 | -$5.03M derived: sum of 2 quarters · filed 2013-03-18 | -$5.90M 10-Q · filed 2012-11-02 | -$8.40M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | -$2.29M 10-K · filed 2013-03-18 | -$3.16M 10-Q · filed 2012-08-08 | -$5.66M derived: sum of 3 quarters · filed 2013-03-18 | -$9.50M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | -$866.00K 10-K · filed 2013-03-18 | -$3.37M derived: sum of 2 quarters · filed 2013-03-18 | -$7.21M derived: sum of 3 quarters · filed 2013-03-18 | -$8.62M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | -$2.50M 10-K · filed 2013-03-18 | -$6.34M derived: sum of 2 quarters · filed 2013-03-18 | -$7.76M derived: sum of 3 quarters · filed 2013-03-18 | -$13.14M 10-K · filed 2013-03-18 |
| 2010-09-30 | -$3.84M 10-K · filed 2013-03-18 | -$5.25M derived: sum of 2 quarters · filed 2013-03-18 | -$10.63M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | -$1.42M 10-K · filed 2013-03-18 | -$6.80M 10-Q · filed 2011-08-05 | ||
| 2010-03-31 | -$5.38M 10-K · filed 2013-03-18 | |||
| 2009-12-31 | -$7.18M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |